Publikationen von 0000-0002-4044-9094
(ORCID: 0000-0002-4044-9094)

Zaremba, Anne, Mohr, Peter, Gutzmer, Ralf, Meier, Friedegund , Pföhler, Claudia, Weichenthal, Michael, Terheyden, Patrick, Forschner, Andrea, Leiter, Ulrike, Ulrich, Jens, Utikal, Jochen, Welzel, Julia, Kaatz, Martin, Gebhardt, Christoffer , Herbst, Rudolf, Sindrilaru, Anca, Dippel, Edgar, Sachse, Michael, Meiss, Frank , Heinzerling, Lucie, Haferkamp, Sebastian, Weishaupt, Carsten, Löffler, Harald, Kreft, Sophia, Griewank, Klaus, Livingstone, Elisabeth, Schadendorf, Dirk, Ugurel, Selma und Zimmer, Lisa (2023) Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG. European Journal of Cancer 188, S. 140-151. Volltext nicht vorhanden.

Haist, Maximilian , Stege, Henner, Rogall, Friederike, Tan, Yuqi , von Wasielewski, Imke, Klespe, Kai Christian, Meier, Friedegund , Mohr, Peter, Kähler, Katharina C, Weichenthal, Michael , Hauschild, Axel, Schadendorf, Dirk, Ugurel, Selma, Lodde, Georg, Zimmer, Lisa, Gutzmer, Ralf, Debus, Dirk, Schilling, Bastian, Kreuter, Alexander, Ulrich, Jens, Meiss, Frank , Herbst, Rudolf, Forschner, Andrea, Leiter, Ulrike, Pfoehler, Claudia, Kaatz, Martin, Ziller, Fabian, Hassel, Jessica C, Tronnier, Michael, Sachse, Michael, Dippel, Edgar, Terheyden, Patrick, Berking, Carola, Heppt, Markus V, Kiecker, Felix, Haferkamp, Sebastian, Gebhardt, Christoffer , Simon, Jan Christoph, Grabbe, Stephan und Loquai, Carmen (2023) Treatment management forBRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 11 (9), e007630. Volltext nicht vorhanden.